Birmingham, West Midlands -- (SBWIRE) -- 12/23/2013 -- Value Penny Stocks issues special report on NII Holdings Inc (NASDAQ:NIHD), Avanir Pharmaceuticals Inc (NASDAQ:AVNR), Novavax, Inc. (NASDAQ:NVAX), Inovio Pharmaceuticals Inc (NYSEMKT:INO).
NII Holdings Inc (NASDAQ:NIHD) opened its last trade at the price of $2.48. Its closing price was $2.57 after gaining 3.21% for the day. The company traded with the total volume of 12.42 million shares, while its average trading volume remained 6.03 million shares. The beta of this stock stands at 1.49. NII Holdings, Inc., through its subsidiaries, provides wireless communication services under the Nextel brand name to businesses and individuals in Mexico, Brazil, Argentina, Peru, and Chile. Its services include mobile telephone service; Nextel Direct Connect and International Direct Connect service, which allows subscribers to talk to each other instantly, on a push-to-talk basis for private one-to-one calls or on group calls.
For How Long NIHD will Fight for Profitability? Read This Trend Analysis report
Avanir Pharmaceuticals Inc (NASDAQ:AVNR) percentage change surged 19.69% to close at $3.43 with the total traded volume of 12.01 million shares, along with average volume of 3.03 million shares. The 52 week range of the stock remained $2.51 - $6.00, while its day lowest price was $2.94. The share price hit the day highest price of $3.44. Avanir Pharmaceuticals, Inc., together with its subsidiaries, is engaged in acquiring, developing, and commercializing novel therapeutic products for the treatment of central nervous system disorders primarily in the United States.
For How Long AVNR’s Gloss will Attract Investors? Find out via this report
Novavax, Inc. (NASDAQ:NVAX) traded on volume of 15.49 million shares in the last session against average volume of 5.36 million shares. The company started its trading session with the price of $4.70 and closed at $4.93 by scoring +5.34%. Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on developing recombinant protein nanoparticle vaccines to address a range of infectious diseases. The company’s technology platform is based on proprietary recombinant vaccine technology that includes virus-like particles (VLPs) and recombinant protein micelle vaccines.
Will NVAX Continue To Move Higher? Find Out Here
Inovio Pharmaceuticals Inc (NYSEMKT:INO) started its last trading session with the price of $2.13 and closed at $2.15 by scoring +0.94%. The stock traded with total volume of 11.65 million shares, while the average trading volume remained 3.03 million shares. The beta value of this stock stands at 3.18. Day range for the stock was $2.06 - $2.21. Inovio Pharmaceuticals, Inc., together with its subsidiaries, engages in the discovery and development of synthetic vaccines and immune therapies focusing on cancers and infectious diseases. The company’s DNA-based SynCon technology enables the design of vaccines capable of providing cross-protection against new, unmatched strains of pathogens, such as influenza.
Why Should Investors Buy INO After The Recent Gain? Just Go Here and Find Out
About Value Penny Stocks
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)